ASX Filings

Opthea receives A$8.8 million R&D Tax Incentive

December 20, 2023

Opthea to Present at the FLORetina 2023 Congress

December 1, 2023

Results of Meeting

November 30, 2023

2023 AGM Chairmans Address

November 30, 2023

Opthea presents at Jefferies 2023 Healthcare Conference

November 10, 2023

Opthea to present at Eyecelerator at AAO

October 31, 2023

Notice of Annual General Meeting/Proxy Form

October 27, 2023

Opthea Appoints U.S. Based Leadership

October 27, 2023

Trading Halt

October 25, 2023

Application for quotation of securities - OPT

October 13, 2023